Literature DB >> 12072960

A new type of dihydroorotate dehydrogenase, type 1S, from the thermoacidophilic archaeon Sulfolobus solfataricus.

Gravgaard Sørensen1, Gert Dandanell.   

Abstract

Dihydroorotate dehydrogenase (DHOD) (EC 1.3.3.1) from the thermoacidophilic archaeon Sulfolobus solfataricus P2 (DSM 1617) was partially purified 3,158-fold, characterized, and the encoding genes identified. Based on enzymological as well as phylogenetic methods, dihydroorotate dehydrogenase from S. solfataricus (DHODS) represents a new type of DHOD, type 1S. Furthermore, it is unable to use any of the (type-specific) natural electron acceptors employed by all other presently known DHODs. DHODS shows optimal activity at 70 degrees C in the pH range 7-8.5. It is capable of using ferricyanide, 2,6-dichlorophenolindophenol (DCIP), Q(0), and molecular oxygen as electron acceptor. Kinetic studies employing ferricyanide indicate a two-site ping-pong mechanism with K(M) values of 44.2+/-1.9 microM for the substrate dihydroorotate and 344+/-21 microM for the electron acceptor ferricyanide, as well as competitive product inhibition with a K(i) of 23.7+/-3.4 microM for the product orotate (OA). The specific activity, as determined from a partially purified sample, is approximately 20 micromol mg(-1) min(-1). DHODS is a heteromeric enzyme comprising a catalytic subunit encoded by pyrD (291 aa; MW=31.1 kDa) and an electron acceptor subunit (208 aa; MW=23.6 kDa), encoded by orf1. DHODS employs a serine as catalytic base, which is unique for a cytosolic DHOD. To our knowledge, this work represents not only the first study on an archaeal DHOD but the first on a nonmesophilic DHOD as well.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12072960     DOI: 10.1007/s00792-001-0249-0

Source DB:  PubMed          Journal:  Extremophiles        ISSN: 1431-0651            Impact factor:   2.395


  6 in total

1.  Identification of Human Dihydroorotate Dehydrogenase Inhibitor by a Pharmacophore-Based Virtual Screening Study.

Authors:  Salvatore Galati; Stefano Sainas; Marta Giorgis; Donatella Boschi; Marco L Lolli; Gabriella Ortore; Giulio Poli; Tiziano Tuccinardi
Journal:  Molecules       Date:  2022-06-07       Impact factor: 4.927

2.  Genes of de novo pyrimidine biosynthesis from the hyperthermoacidophilic crenarchaeote Sulfolobus acidocaldarius: novel organization in a bipolar operon.

Authors:  Thia-Lin Thia-Toong; Martine Roovers; Virginie Durbecq; Daniel Gigot; Nicolas Glansdorff; Daniel Charlier
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

3.  Inhibitor binding in a class 2 dihydroorotate dehydrogenase causes variations in the membrane-associated N-terminal domain.

Authors:  Majbritt Hansen; Jérôme Le Nours; Eva Johansson; Torben Antal; Alexandra Ullrich; Monika Löffler; Sine Larsen
Journal:  Protein Sci       Date:  2004-04       Impact factor: 6.725

Review 4.  DHODH and cancer: promising prospects to be explored.

Authors:  Yue Zhou; Lei Tao; Xia Zhou; Zeping Zuo; Jin Gong; Xiaocong Liu; Yang Zhou; Chunqi Liu; Na Sang; Huan Liu; Jiao Zou; Kun Gou; Xiaowei Yang; Yinglan Zhao
Journal:  Cancer Metab       Date:  2021-05-10

5.  Identifying reaction modules in metabolic pathways: bioinformatic deduction and experimental validation of a new putative route in purine catabolism.

Authors:  Matthieu Barba; Raphaël Dutoit; Christianne Legrain; Bernard Labedan
Journal:  BMC Syst Biol       Date:  2013-10-05

6.  Crystal structures of FMN-bound and FMN-free forms of dihydroorotate dehydrogenase from Trypanosoma brucei.

Authors:  Tomomi Kubota; Osamu Tani; Tomohiko Yamaguchi; Ichiji Namatame; Hitoshi Sakashita; Koji Furukawa; Kazuhiko Yamasaki
Journal:  FEBS Open Bio       Date:  2018-03-06       Impact factor: 2.693

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.